TITLE

Immunosuppressive drugs. I

PUB. DATE
December 1970
SOURCE
British Medical Journal;12/12/1970, Vol. 4 Issue 5736, p663
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098689

 

Related Articles

  • Immunosuppressive and calcimimetic drug-drug interactions. Izzedine, Hassane; Launay-Vacher, Vincent; Karie, Svetlana; Deray, Gilbert // Kidney International;Oct2005, Vol. 68 Issue 4, p1903 

    Presents a letter to the editor about the immunosuppressive and calcimimetic drug-drug interactions.

  • Managing panuveitis without steroids can be difficult. Cooney, Michael J.; Jaffe, Glenn // Ophthalmology Times;09/01/99, Vol. 24 Issue 17, p18 

    Discusses the use of immunosuppressive agents as an alternative to the management of panuveitis without steroids. Information on the classes of immunosuppressive agents; Reminder after the administration of immunosuppressive drugs.

  • Immunosuppressive drugs: Beyond glucocorticoids. Pressler, Barrak // Veterinary Medicine;Aug2010, Vol. 105 Issue 8, p364 

    The article reviews the article "Immunosuppressive Drugs: Beyong Glucocorticoids," by Barrack Pressler.

  • Investigation on correlation of genotype combinations of VEGF-1154 G/A and -2578 C/A genotypes with suppression of VEGF production after treatment with immunosuppressive drugs. Mohammadi, Mojgan; Ollier, W. E. R.; Hutchinson, I. V. // Journal of Medical Genetics;Sep2005, Vol. 42, pS93 

    Presents an abstract of the article "Investigation on Correlation of Genotype Combinations of VEGF-1154 G/A and -2578 C/A Genotypes With Suppression of VEGF Production After Treatment With Immunosuppressive Drugs," by Mojgan Mohammadi, W. E. R. Ollier, and I. V. Hutchinson.

  • Myelodysplastic syndrome with signs of auto-immune disease in a patient with renal allograft. Förster, E.; Birnbacher, R.; Mann, G.; Balzar, E.; Radaszkiewicz, T.; Urbanek, R.; Förster, E // European Journal of Pediatrics;1998, Vol. 157 Issue 4, p351 

    Presents a medical case of a patient with myelodysplastic syndrome (MDS). History of the patient; Description of immunosuppressed individuals; Side effects of immunosuppressive drugs on MDS patients.

  • Where do we stand on drug treatment for ulcerative colitis? Korelitz, Burton I.; Korelitz, B I // Annals of Internal Medicine;4/15/92, Vol. 116 Issue 8, p692 

    Editorial. Enumerates and discusses the effectiveness of several drug treatments for ulcerative colitis. Sulfasalazine; Immunosuppressive drugs; Olsalazine.

  • Cyclosporine: a new immunosuppressive agent for organ transplantation. Cohen, David J.; Loertscher, Rolf; Rubin, Mario F.; Tilney, Nicholas L.; Carpenter, Charles B.; Strom, Terry B.; Cohen, D J; Loertscher, R; Rubin, M F; Tilney, N L; Carpenter, C B; Strom, T B // Annals of Internal Medicine;Nov84, Vol. 101 Issue 5, p667 

    Cyclosporine, a cyclic endecapeptide of fungal origin, has recently been released for use in clinical transplantation. Trials in kidney, heart, liver and bone marrow recipients were encouraging: 1-year graft survival rates were 70% to 80% for kidney and heart recipients, and 60% to 65% for liver...

  • IMMUNOSUPPRESSANTS.  // Davis's Drug Guide for Nurses, 9th edition;2005, pC58 

    Provides pharmacologic information on immunosuppressants. Pharmacokinetics; Side effects of the drug; Drug interactions; Evaluation of effectiveness.

  • mycophenolate.  // Davis's Drug Guide for Nurses, 9th edition;2005, p717 

    Presents information on mycophenolate, an immunosuppressant. Pharmacokinetics; Adverse reactions and side effects; Drug interactions; Required dosage of the drug for adults.

  • Reply from the Authors. Ballermann, Barbara J. // Kidney International;Oct2005, Vol. 68 Issue 4, p1902 

    Presents a letter to the editor in response to the article about the immunosuppressive and calcimimetic drug-drug interactions.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics